Dennis Mulroy - Net Worth and Insider Trading
Dennis Mulroy Net Worth
The estimated net worth of Dennis Mulroy is at least $64,948 dollars as of 2024-12-27. Dennis Mulroy is the CHIEF FINANCIAL OFFICER of AnaptysBio Inc and owns about 4,744 shares of AnaptysBio Inc (ANAB) stock worth over $61,838. Dennis Mulroy is also the CFO of La Jolla Pharmaceutical Co and owns about 500 shares of La Jolla Pharmaceutical Co (LJPC) stock worth over $3,110. Details can be seen in Dennis Mulroy's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dennis Mulroy has not made any transactions after 2024-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dennis Mulroy
Dennis Mulroy Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennis Mulroy owns 3 companies in total, including AnaptysBio Inc (ANAB) , La Jolla Pharmaceutical Co (LJPC) , and Gene Biotherapeutics Inc (CRXM) .
Click here to see the complete history of Dennis Mulroy’s form 4 insider trades.
Insider Ownership Summary of Dennis Mulroy
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ANAB | AnaptysBio Inc | 2024-09-16 | Chief Financial Officer |
| LJPC | La Jolla Pharmaceutical Co | 2017-03-03 | Chief Financial Officer |
| CRXM | Gene Biotherapeutics Inc | 2014-02-28 | Chief Financial Officer |
Dennis Mulroy Latest Holdings Summary
Dennis Mulroy currently owns a total of 2 stocks. Among these stocks, Dennis Mulroy owns 4,744 shares of AnaptysBio Inc (ANAB) as of September 16, 2024, with a value of $61,838 and a weighting of 95.21%. Dennis Mulroy also owns 500 shares of La Jolla Pharmaceutical Co (LJPC) as of March 3, 2017, with a value of $3,110 and a weighting of 4.79%.
Latest Holdings of Dennis Mulroy
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANAB | AnaptysBio Inc | 2024-09-16 | 4,744 | 13.04 | 61,838 |
| LJPC | La Jolla Pharmaceutical Co | 2017-03-03 | 500 | 6.22 | 3,110 |
Holding Weightings of Dennis Mulroy
Dennis Mulroy Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennis Mulroy has made a total of 5 transactions in AnaptysBio Inc (ANAB) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in AnaptysBio Inc is the sale of 12,220 shares on September 16, 2024, which brought Dennis Mulroy around $487,700.
According to the SEC Form 4 filings, Dennis Mulroy has made a total of 0 transactions in La Jolla Pharmaceutical Co (LJPC) over the past 5 years. The most-recent trade in La Jolla Pharmaceutical Co is the acquisition of 500 shares on March 3, 2017, which cost Dennis Mulroy around $16,975.
Insider Trading History of Dennis Mulroy
- 1
Dennis Mulroy Trading Performance
GuruFocus tracks the stock performance after each of Dennis Mulroy's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dennis Mulroy is -13.99%. GuruFocus also compares Dennis Mulroy's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dennis Mulroy within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dennis Mulroy's insider trading performs compared to the benchmark.
Performance of Dennis Mulroy
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.58 | | | | | |
| Relative Return to S&P 500(%) | -12.56 | | | | | |
Dennis Mulroy Ownership Network
Dennis Mulroy Owned Company Details
What does AnaptysBio Inc do?
Who are the key executives at AnaptysBio Inc?
Dennis Mulroy is the Chief Financial Officer of AnaptysBio Inc. Other key executives at AnaptysBio Inc include Chief Medical Officer Paul F. Lizzul , General Counsel Eric J Loumeau , and 10 percent owner Ecor1 Capital, Llc .
AnaptysBio Inc (ANAB) Insider Trades Summary
Over the past 18 months, Dennis Mulroy made 5 insider transaction in AnaptysBio Inc (ANAB) with a net sale of 24,965. Other recent insider transactions involving AnaptysBio Inc (ANAB) include a net sale of 11,879 shares made by Paul F. Lizzul , a net sale of 26,687 shares made by Eric J Loumeau , and a net sale of 21,950 shares made by Hollings Renton .
In summary, during the past 3 months, insiders sold 10,000 shares of AnaptysBio Inc (ANAB) in total and bought 0 shares, with a net sale of 10,000 shares. During the past 18 months, 243,237 shares of AnaptysBio Inc (ANAB) were sold and 273,972 shares were bought by its insiders, resulting in a net purchase of 30,735 shares.
AnaptysBio Inc (ANAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
AnaptysBio Inc Insider Transactions
Dennis Mulroy Mailing Address
Above is the net worth, insider trading, and ownership report for Dennis Mulroy. Currently GuruFocus does not have mailing address information for Dennis Mulroy.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
